Cargando…

Harms associated with taking nalmefene for substance use and impulse control disorders: A systematic review and meta-analysis of randomised controlled trials

IMPORTANCE: Nalmefene is a newly approved drug for alcohol use disorder, but the risk of harms has not been evaluated from empirical trial evidence. OBJECTIVE: To assess the harm of nalmefene administered to individuals diagnosed with substance use or impulse control disorders by performing a system...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johansen, Karina Glies Vincents, Tarp, Simon, Astrup, Arne, Lund, Hans, Pagsberg, Anne K., Christensen, Robin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574613/ https://www.ncbi.nlm.nih.gov/pubmed/28850596 http://dx.doi.org/10.1371/journal.pone.0183821

Ejemplares similares

Effectiveness of workplace interventions in rehabilitating musculoskeletal disorders and preventing its consequences among workers with physical and sedentary employment: systematic review protocol
por: Seeberg, Karina Glies Vincents, et al.
Publicado: (2019)

A Systematic Review of Workplace Interventions to Rehabilitate Musculoskeletal Disorders Among Employees with Physical Demanding Work
por: Sundstrup, Emil, et al.
Publicado: (2020)

Barriers and Facilitators of Re-Employment among Senior Workers: Prospective Cohort Study
por: Thomassen, Kristina, et al.
Publicado: (2022)

The effects of nalmefene on the impulsive and reflective system in alcohol use disorder: A resting-state fMRI study
por: Grundinger, Nadja, et al.
Publicado: (2022)

The More You Take It, the Better It Works: Six-Month Results of a Nalmefene Phase-IV Trial
por: Barrio, Pablo, et al.
Publicado: (2019)

The Predictive Value of Impulsivity and Risk-Taking Measures for Substance Use in Substance Dependent Offenders
por: Rieser, Nathalie M., et al.
Publicado: (2019)

Nalmefene in alcohol‐dependent patients with a high drinking risk: Randomized controlled trial
por: Miyata, Hisatsugu, et al.
Publicado: (2019)

Nalmefene: a new approach to the treatment of alcohol dependence
por: Paille, François, et al.
Publicado: (2014)

In Vitro and In Vivo Evaluations of PLGA Microspheres Containing Nalmefene
por: Xie, Xiangyang, et al.
Publicado: (2015)

Antipsychotic treatment for children and adolescents with schizophrenia spectrum disorders: protocol for a network meta-analysis of randomised trials
por: Pagsberg, A K, et al.
Publicado: (2014)

The Interplay between Multimorbidity, Physical Work Demands and Work Ability: Cross-Sectional Study among 12,879 Senior Workers
por: Seeberg, Karina Glies Vincents, et al.
Publicado: (2022)

The efficacy of nalmefene on anesthetic recovery of patients: a study protocol for a multicenter randomized controlled trial
por: Ma, Xiaowen, et al.
Publicado: (2023)

Nalmefene: a new approach to the treatment of alcohol dependence [Corrigendum]
Publicado: (2015)

Evaluation in alcohol use disorders – insights from the nalmefene experience
por: Naudet, Florian, et al.
Publicado: (2016)

Low-dose nalmefene pretreatment reduces etomidate-induced myoclonus: A randomized, double-blind controlled trial
por: Shan, Guofa, et al.
Publicado: (2023)

Patient preferences and perspectives regarding reducing alcohol consumption: role of nalmefene
por: Luquiens, Amandine, et al.
Publicado: (2014)

Drinking Levels and Profiles of Alcohol Addicted Rats Predict Response to Nalmefene
por: Foo, Jerome Clifford, et al.
Publicado: (2019)

Long‐term safety and efficacy of nalmefene in Japanese patients with alcohol dependence
por: Higuchi, Susumu, et al.
Publicado: (2020)

Sufentanil combined with nalmefene reduce the adverse events in recovery period of patients undergoing uvulopalatopharyngoplasty – A randomized controlled trial
por: Wang, Jin, et al.
Publicado: (2023)

Harm to Others From Substance Use and Abuse
por: Lund, Ingunn Olea, et al.
Publicado: (2016)

Nalmefene and alcohol dependence: A new approach or the same old unacceptable marketing?
por: Braillon, Alain, et al.
Publicado: (2015)

Clinical relevance of nalmefene versus placebo in alcohol treatment: Reduction in mortality risk
por: Roerecke, Michael, et al.
Publicado: (2015)

Weak evidence on nalmefene creates dilemmas for clinicians and poses questions for regulators and researchers
por: Fitzgerald, Niamh, et al.
Publicado: (2016)

Impulsive action: emotional impulses and their control
por: Frijda, Nico H., et al.
Publicado: (2014)

Harmful chemical substances
por: Bandman, A L, et al.
Publicado: (1992)

Family-Based Interventions for the Prevention of Substance Abuse and Other Impulse Control Disorders in Girls
por: Kumpfer, K. L.
Publicado: (2014)

Impulsivity and self-harm in adolescence: a systematic review
por: Lockwood, Joanna, et al.
Publicado: (2016)

Harm to Others from Substance Use and Abuse: The Underused Potential in Nationwide Registers
por: Lund, Ingunn Olea, et al.
Publicado: (2015)

Trait Impulsivity and Anhedonia: Two Gateways for the Development of Impulse Control Disorders in Parkinson’s Disease?
por: Houeto, Jean-Luc, et al.
Publicado: (2016)

Visualising harms in publications of randomised controlled trials: consensus and recommendations
por: Phillips, Rachel, et al.
Publicado: (2022)

Nalmefene vs. dexmedetomidine for prevention of postoperative hyperalgesia in patients undergoing laparoscopic gynecological surgery with remifentanil infusion: A randomized double-blind controlled trial
por: Jia, Zhen, et al.
Publicado: (2023)

Risk-Taking and Impulsivity: The Role of Mood States and Interoception
por: Herman, Aleksandra M., et al.
Publicado: (2018)

Assessing Impulsivity in Humans and Rodents: Taking the Translational Road
por: Esteves, Madalena, et al.
Publicado: (2021)

Editorial: Behavioral Addictions, Risk-Taking, and Impulsive Choice
por: Bortolato, Marco, et al.
Publicado: (2022)

Impulsivity and Risk-Taking Behavior in School-Going Adolescents
por: Soni, Ujjwal, et al.
Publicado: (2023)

Safety and Persistence of Nalmefene Treatment for Alcohol Dependence. Results from Two Post-authorisation Safety Studies
por: Chick, Jonathan, et al.
Publicado: (2021)

Effect of Sufentanil Combined with Nalmefene Assisted Surface Anesthesia on Transnasal Endotracheal Intubation Guided by Fiberoptic Bronchoscope
por: Zhao, Zhanqi, et al.
Publicado: (2022)

Longitudinal Associations among Impulsivity, Friend Substance Use, and Adolescent Substance Use
por: Farley, Julee P., et al.
Publicado: (2015)

Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials
por: Palpacuer, Clément, et al.
Publicado: (2015)

To Take the Stairs or Not to Take the Stairs? Employing the Reflective–Impulsive Model to Predict Spontaneous Physical Activity
por: Daou, Marcos, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9m90su58ljjevsts2ggcossj4i